The hydrogenation of CO to methanol can be achieved using a single molecular organometallic catalyst. Whereas homogeneous catalysts were previously believed to allow the hydrogenation only formate esters as stable intermediates, the present mechanistic study demonstrates that the multistep transformation can occur directly on the Ru-Triphos (Triphos = 1,1,1-tris(diphenylphosphinomethyl)ethane) centre. The cationic formate complex [(Triphos)Ru(η-OCH)(S)] (S = solvent) was identified as the key intermediate, leading to the synthesis of the analogous acetate complex as a robust and stable precursor for the catalytic transformation. A detailed mechanistic study using DFT calculations shows that a sequential series of hydride transfer and protonolysis steps can account for the transformation of CO formate/formic acid to hydroxymethanolate/formaldehyde and finally methanolate/methanol within the coordination sphere of a single Ru-Triphos-fragment. All experimental results of the systematic parameter optimisation are fully consistent with this mechanistic picture. Based on these findings, a biphasic system consisting of HO and 2-MTHF was developed, in which the active cationic Ru-complex resides in the organic phase for recycling and methanol is extracted with the aqueous phase.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085670 | PMC |
http://dx.doi.org/10.1039/c4sc02087a | DOI Listing |
Discov Oncol
January 2025
Department of Oncology and Gynecology, The First Affiliated Hospital of Bengbu Medical University, No. 287, Changhuai Road, Longzihu District, Bengbu, Anhui, China.
Ovarian cancer is a common malignant tumor in women, exhibiting a certain sensitivity to chemotherapy drugs like gemcitabine (GEM). This study, through the analysis of ovarian cancer single-cell RNA sequencing (scRNA-seq) data and transcriptome data post-GEM treatment, identifies the pivotal role of hypoxia-inducible factor 1 alpha (HIF-1α) in regulating the treatment process. The results reveal that HIF-1α modulates the expression of VEGF-B, thereby inhibiting the fibroblast growth factor 2 (FGF2)/FGFR1 signaling pathway and impacting tumor formation.
View Article and Find Full Text PDFWith complex pathogenesis, Alzheimer's disease (AD) is a neurological illness that has worsened over time. Inter-organ crosstalk, which is essential for coordinating organ function and maintaining homeostasis, is involved in multiple physiological and pathological events. Increasing evidence suggests that AD is closely associated with multiple diseases of peripheral organs, including the gut, adipose tissue, liver, and bone.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, Shanghai, China.
Background: Pathological tau plays critical roles in many neurodegenerative diseases (NDD), including Alzheimer's disease (AD). However, the mechanisms underlying the initial tau pathogenesis are largely unknown. Extensive tau pathology has been observed in the brains with chronic traumatic encephalopathy (CTE), suggesting repeated traumatic brain injury (rTBI) correlates with tau pathogenesis.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
UCSF Bakar Aging Research Institute, San Francisco, CA, USA.
Background: Aging drives cellular and cognitive impairments in the adult brain. It is imperative to gain mechanistic insight into what drives aging phenotypes in the brain in order to maintain, and even restore, functional integrity in the elderly.
Method: We, and others, have shown that systemic interventions - such as heterochronic parabiosis (in which a young and old circulatory system are joined) and administration of young blood or exercise induced blood factors - can reverse age-related impairments in regenerative, synaptic and inflammatory processes, as well as rescue cognitive faculties in the aged brain.
Alzheimers Dement
December 2024
Division of Neurogeriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden.
Background: Alzheimer's disease (AD) is associated with synaptic and memory dysfunction. A pathological hallmark of the disease is reactive astrogliosis, with reactive astrocytes surrounding amyloid plaques in the brain. Astrocytes have also been shown to be actively involved in disease progression, nevertheless, mechanistic information about their role in synaptic transmission during AD pathology is lacking.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!